首页> 美国卫生研究院文献>Therapeutic Advances in Medical Oncology >Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study

【2h】

Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study

机译：一项前瞻性队列研究表明在绝经后的早期乳腺癌女性中类固醇芳香酶抑制剂对脂质谱的影响比非类固醇芳香酶抑制剂更好。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aromatase inhibitors (AIs) influence blood lipid profiles. However, relatively few studies have directly compared the treatment effects of steroidal and nonsteroidal AIs.

机译：芳香酶抑制剂（AIs）影响血脂状况。但是，很少有研究直接比较类固醇和非类固醇AI的治疗效果。

著录项

期刊名称 Therapeutic Advances in Medical Oncology
作者
Xue Wang; Anjie Zhu; Jiayu Wang; Fei Ma; Jing Liu; Ying Fan; Yang Luo; Pin Zhang; Qing Li; Binghe Xu; Peng Yuan;
展开▼
作者单位

展开▼
年(卷),期 2020(12),-1
年度 2020
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Breast cancer; Aromatase inhibitors; Exemestane; Postmenopausal women; Lipid profile; Low-density lipoprotein cholesterol;

机译：乳腺癌;芳香酶抑制剂;依西美坦;绝经后妇女;脂质状况;低密度脂蛋白胆固醇;

相似文献

外文文献
中文文献
专利

1. Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study [J] . Xue Wang, Anjie Zhu, Jiayu Wang, Therapeutic advances in medical oncology. . 2020,第12期

机译：甾体芳香酶抑制剂对脂质谱具有比未早期乳腺癌的非甾体芳族酶抑制剂的脂质谱具有更有利的作用：一个未来的队列研究
2. Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study [J] . Hong Namki, Yoon Han Gyul, Seo Da Hea, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：新出现脂肪肝和脂质变化的不同模式与患有早期乳腺癌的绝经后妇女的三莫莫毒素与芳香酶抑制剂的变化：倾向分数匹配的队列研究
3. Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study [J] . Xie Yizhao, Li Yi, Zhang Yinbin, Clinical breast cancer . 2019,第3期

机译：富勒斯特朗斯500毫克与绝经后患者的患者患有转移性乳腺癌的患者患者临床实践中的辅助非甾族芳香酶抑制剂：多中心回顾性研究
4. Aromatase Inhibitors in Prevention - Data from the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial and the Design of IBIS-II (the Second International Breast Cancer Intervention Study) [C] . Jack Cuzick International Society of Cancer Chemoprevention . 2003

机译：预防芳族酶抑制剂 - 来自ATAC（ARIMIDEX，Tamoxifen单独或组合或组合的数据）的数据和IBIS-II的设计（第二次国际乳腺癌干预研究）
5. The Genetics of Aromatase Inhibitor-related Phenotypes in Postmenopausal Women with ER+ Breast Cancer [D] . Dudenkov, Tanda Tosia Murray. 2017

机译：ER +乳腺癌绝经后妇女芳香酶抑制剂相关表型的遗传
6. CORRIGENDUM to Steroidal aromatase inhibitors have a more favorable effecton lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women withearly breast cancer: a prospective cohort study [O] . 2020

机译：甾体芳香酶抑制剂具有更有利的效果在绝经后妇女中的非甾体芳香酶抑制剂比脂质曲线早期乳腺癌：一个潜在的队列研究
7. CORRIGENDUM to “Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study” [O] . 2020

机译：“甾体芳香酶抑制剂的静脉曲张对脂质谱具有比未早期乳腺癌的非甾族芳香酶抑制剂具有更有利的作用：一个预期的队列研究”

Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study

摘要

著录项

相似文献

相关主题

期刊订阅